Copyright © 2008 M. G. Hall et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. D. J. Mangelsdorf, C. Thummel, M. Beato, et al., “The nuclear receptor superfamily: the second decade,” Cell, vol. 83, no. 6, pp. 835–839, 1995. View at Publisher · View at Google Scholar
2. A. L. Bookout, Y. Jeong, M. Downes, R. T. Yu, R. M. Evans, and D. J. Mangelsdorf, “Anatomical profiling of nuclear receptor expression revealsa hierarchical transcriptional network,” Cell, vol. 126, no. 4, pp. 789–799, 2006. View at Publisher · View at Google Scholar · View at PubMed
3. A. Chawla, J. J. Repa, R. M. Evans, and D. J. Mangelsdorf, “Nuclear receptors and lipid physiology: opening the X-files,” Science, vol. 294, no. 5548, pp. 1866–1870, 2001. View at Publisher · View at Google Scholar · View at PubMed
4. F. Gofflot, N. Chartoire, L. Vasseur, et al., “Systematic gene expression mapping clusters nuclear receptors according to their function in the brain,” Cell, vol. 131, no. 2, pp. 405–418, 2007. View at Publisher · View at Google Scholar · View at PubMed
5. J. N. Feige, L. Gelman, L. Michalik, B. Desvergne, and W. Wahli, “From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions,” Progress in Lipid Research, vol. 45, no. 2, pp. 120–159, 2006. View at Publisher · View at Google Scholar · View at PubMed
6. O. Braissant, F. Foufelle, C. Scotto, M. Dauca, and W. Wahli, “Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-$\alpha$, -$\beta$, and -$\gamma$ in the adult rat,” Endocrinology, vol. 137, no. 1, pp. 354–366, 1996. View at Publisher · View at Google Scholar
7. J. M. Peters, S. S. T. Lee, W. Li, et al., “Growths, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor $\beta$($\delta$),” Molecular and Cellular Biology, vol. 20, no. 14, pp. 5119–5128, 2000. View at Publisher · View at Google Scholar
8. C. Dreyer, G. Krey, H. Keller, F. Givel, G. Helftenbein, and W. Wahli, “Control of the peroxisomal $\beta$-oxidation pathway by a novel family of nuclear hormone receptors,” Cell, vol. 68, no. 5, pp. 879–887, 1992. View at Publisher · View at Google Scholar
9. I. Issemann and S. Green, “Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators,” Nature, vol. 347, no. 6294, pp. 645–650, 1990. View at Publisher · View at Google Scholar · View at PubMed
10. S. A. Kliewer, B. M. Forman, B. Blumberg, et al., “Differential expression and activation of a family of murine peroxisome proliferator-activated receptors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 15, pp. 7355–7359, 1994. View at Publisher · View at Google Scholar
11. Y. Barak, D. Liao, W. He, et al., “Effects of peroxisome proliferator-activated receptor $\delta$ on placentation, adiposity, and colorectal cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 1, pp. 303–308, 2002. View at Publisher · View at Google Scholar · View at PubMed
12. K. Nadra, S. I. Anghel, E. Joye, et al., “Differentiation of trophoblast giant cells and their metabolic functions are dependent on peroxisome proliferator-activated receptor $\beta$/$\delta$,” Molecular and Cellular Biology, vol. 26, no. 8, pp. 3266–3281, 2006. View at Publisher · View at Google Scholar · View at PubMed
13. L. Michalik, B. Desvergne, N. S. Tan, et al., “Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)$\alpha$ and PPAR$\beta$ mutant mice,” Journal of Cell Biology, vol. 154, no. 4, pp. 799–814, 2001. View at Publisher · View at Google Scholar · View at PubMed
14. F. Varnat, B. B. Heggeler, P. Grisel, et al., “PPAR$\beta$/$\delta$ regulates paneth cell differentiation via controlling the hedgehog signaling pathway,” Gastroenterology, vol. 131, no. 2, pp. 538–553, 2006. View at Publisher · View at Google Scholar · View at PubMed
15. E. Bedu, D. Desplanches, J. Pequignot, B. Bordier, and B. Desvergne, “Double gene deletion reveals the lack of cooperation between PPAR$\alpha$ and PPAR$\beta$ in skeletal muscle,” Biochemical and Biophysical Research Communications, vol. 357, no. 4, pp. 877–881, 2007. View at Publisher · View at Google Scholar · View at PubMed
16. N. S. Tan, G. Icre, A. Montagner, B. Bordier-Ten Heggeler, W. Wahli, and L. Michalik, “The nuclear hormone receptor peroxisome proliferator-activated receptor $\beta$/$\delta$ potentiates cell chemotactism, polarization, and migration,” Molecular and Cellular Biology, vol. 27, no. 20, pp. 7161–7175, 2007. View at Publisher · View at Google Scholar · View at PubMed
17. O. Braissant and W. Wahli, “Differential expression of peroxisome proliferator-activated receptor-$\alpha$, -$\beta$, and -$\gamma$ during rat embryonic development,” Endocrinology, vol. 139, no. 6, pp. 2748–2754, 1998. View at Publisher · View at Google Scholar
18. G. Q. Xing, L. X. Zhang, L. Zhang, et al., “Rat PPAR$\delta$ contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei,” Biochemical and Biophysical Research Communications, vol. 217, no. 3, pp. 1015–1025, 1995. View at Publisher · View at Google Scholar
19. J. W. Woods, M. Tanen, D. J. Figueroa, et al., “Localization of PPAR$\delta$ in murine central nervous system: expression in oligodendrocytes and neurons,” Brain Research, vol. 975, no. 1-2, pp. 10–21, 2003. View at Publisher · View at Google Scholar
20. A. Cimini, E. Benedetti, L. Cristiano, et al., “Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons,” Neuroscience, vol. 130, no. 2, pp. 325–337, 2005. View at Publisher · View at Google Scholar · View at PubMed
21. H. Higashiyama, A. N. Billin, Y. Okamoto, M. Kinoshita, and S. Asano, “Expression profiling of peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray,” Histochemistry and Cell Biology, vol. 127, no. 5, pp. 485–494, 2007. View at Publisher · View at Google Scholar · View at PubMed
22. S. Moreno, S. Farioli-vecchioli, and M. P. Cerù, “Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS,” Neuroscience, vol. 123, no. 1, pp. 131–145, 2004. View at Publisher · View at Google Scholar
23. L. Cristiano, A. Bernardo, and M. P. Cerù, “Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes,” Journal of Neurocytology, vol. 30, no. 8, pp. 671–683, 2001. View at Publisher · View at Google Scholar
24. L. Cristiano, A. Cimini, S. Moreno, A. M. Ragnelli, and M. P. Cerù, “Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures,” Neuroscience, vol. 131, no. 3, pp. 577–587, 2005. View at Publisher · View at Google Scholar · View at PubMed
25. S. Akanuma, S. Hori, S. Ohtsuki, M. Fujiyoshi, and T. Terasaki, “Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier,” Neurochemistry International, vol. 52, no. 4-5, pp. 669–674, 2008. View at Publisher · View at Google Scholar · View at PubMed
26. E. E. Girroir, H. E. Hollingshead, P. He, B. Zhu, G. H. Perdew, and J. M. Peters, “Quantitative expression patterns of peroxisome proliferator-activated receptor-$\beta$/$\delta$ (PPAR$\beta$/$\delta$) protein in mice,” Biochemical and Biophysical Research Communications, vol. 371, no. 3, pp. 456–461, 2008. View at Publisher · View at Google Scholar · View at PubMed
27. F. Bogazzi, L. D. Hudson, and V. M. Nikodem, “A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor,” The Journal of Biological Chemistry, vol. 269, no. 16, pp. 11683–11686, 1994.
28. P. A. Grimaldi, “Regulatory functions of PPAR$\beta$ in metabolism: implications for the treatment of metabolic syndrome,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 983–990, 2007. View at Publisher · View at Google Scholar · View at PubMed
29. Y.-X. Wang, C.-H. Lee, S. Tiep, et al., “Peroxisome-proliferator-activated receptor $\delta$ activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar
30. C.-H. Lee, P. Olson, A. Hevener, et al., “PPAR$\delta$ regulates glucose metabolism and insulin sensitivity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 9, pp. 3444–3449, 2006. View at Publisher · View at Google Scholar · View at PubMed
31. T. A. Rosenberger, J. T. Hovda, and J. M. Peters, “Targeted disruption of peroxisomal proliferator-activated receptor $\beta$ ($\delta$) results in distinct gender differences in mouse brain phospholipid and esterified FA levels,” Lipids, vol. 37, no. 5, pp. 495–500, 2002. View at Publisher · View at Google Scholar
32. S. Huyghe, H. Schmalbruch, K. De Gendt, et al., “Peroxisomal multifunctional protein 2 is essential for lipid homeostasis in Sertoli cells and male fertility in mice,” Endocrinology, vol. 147, no. 5, pp. 2228–2236, 2006. View at Publisher · View at Google Scholar · View at PubMed
33. S. Basu-Modak, O. Braissant, P. Escher, B. Desvergne, P. Honegger, and W. Wahli, “Peroxisome proliferator-activated receptor $\beta$ regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures,” The Journal of Biological Chemistry, vol. 274, no. 50, pp. 35881–35888, 1999. View at Publisher · View at Google Scholar
34. A. T. Campagnoni and W. B. Macklin, “Cellular and molecular aspects of myelin protein gene expression,” Molecular Neurobiology, vol. 2, no. 1, pp. 41–89, 1988. View at Publisher · View at Google Scholar
35. X. Huang, Y. Litingtung, and C. Chiang, “Ectopic sonic hedgehog signaling impairs telencephalic dorsal midline development: implication for human holoprosencephaly,” Human Molecular Genetics, vol. 16, no. 12, pp. 1454–1468, 2007. View at Publisher · View at Google Scholar · View at PubMed
36. M. D. Leibowitz, C. Fiévet, N. Hennuyer, et al., “Activation of PPAR$\delta$ alters lipid metabolism in db/db mice,” FEBS Letters, vol. 473, no. 3, pp. 333–336, 2000. View at Publisher · View at Google Scholar
37. W. R. Oliver, Jr., J. L. Shenk, M. R. Snaith, et al., “A selective peroxisome proliferator-activated receptor $\delta$ agonist promotes reverse cholesterol transport,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5306–5311, 2001. View at Publisher · View at Google Scholar · View at PubMed
38. H. Vosper, L. Patel, T. L. Graham, et al., “The peroxisome proliferator-activated receptor $\delta$ promotes lipid accumulation in human macrophages,” The Journal of Biological Chemistry, vol. 276, no. 47, pp. 44258–44265, 2001. View at Publisher · View at Google Scholar · View at PubMed
39. M.-Q. Man, E.-H. Choi, M. Schmuth, et al., “Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing,” Journal of Investigative Dermatology, vol. 126, no. 2, pp. 386–392, 2006. View at Publisher · View at Google Scholar · View at PubMed
40. Y. J. Jiang, P. Kim, P. M. Elias, and K. R. Feingold, “LXR and PPAR activators stimulate cholesterol sulfotransferase type 2 isoform 1b in human keratinocytes,” Journal of Lipid Research, vol. 46, no. 12, pp. 2657–2666, 2005. View at Publisher · View at Google Scholar · View at PubMed
41. J. M. Dietschy and S. D. Turley, “Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal,” Journal of Lipid Research, vol. 45, no. 8, pp. 1375–1397, 2004. View at Publisher · View at Google Scholar · View at PubMed
42. C. Bastie, D. Holst, D. Gaillard, C. Jehl-Pietri, and P. A. Grimaldi, “Expression of peroxisome proliferator-activated receptor PPAR$\delta$ promotes induction of PPAR$\gamma$ and adipocyte differentiation in 3T3C2 fibroblasts,” The Journal of Biological Chemistry, vol. 274, no. 31, pp. 21920–21925, 1999. View at Publisher · View at Google Scholar
43. J. N. Feige, L. Gelman, D. Rossi, et al., “The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor $\gamma$ modulator that promotes adipogenesis,” The Journal of Biological Chemistry, vol. 282, no. 26, pp. 19152–19166, 2007. View at Publisher · View at Google Scholar · View at PubMed
44. N. S. Tan, L. Michalik, N. Noy, et al., “Critical roles of PPAR$\beta$/$\delta$ in keratinocyte response to inflammation,” Genes & Development, vol. 15, no. 24, pp. 3263–3277, 2001. View at Publisher · View at Google Scholar · View at PubMed
45. A. Cimini, L. Cristiano, E. Benedetti, B. D'Angelo, and M. P. Cerù, “PPARs expression in adult mouse neural stem cells: modulation of PPARs during astroglial differentiaton of NSC,” PPAR Research, vol. 2007, Article ID 48242, 10 pages, 2007. View at Publisher · View at Google Scholar · View at PubMed
46. I. Saluja, J. G. Granneman, and R. P. Skoff, “PPAR $\delta$ agonists stimulate oligodendrocyte differentiation in tissue culture,” Glia, vol. 33, no. 3, pp. 191–204, 2001. View at Publisher · View at Google Scholar
47. J. Granneman, R. Skoff, and X. Yang, “Member of the peroxisome proliferator-activated receptor family of transcription factors is differentially expressed by oligodendrocytes,” Journal of Neuroscience Research, vol. 51, no. 5, pp. 563–573, 1998. View at Publisher · View at Google Scholar
48. B. A. Barres, M. A. Lazar, and M. C. Raff, “A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development,” Development, vol. 120, no. 5, pp. 1097–1108, 1994.
49. J. W. DeWille and S. J. Farmer, “Postnatal dietary fat influences mRNAS involved in myelination,” Developmental Neuroscience, vol. 14, no. 1, pp. 61–68, 1992.
50. S. Salvati, M. Sanchez, L. M. Campeggi, G. Suchanek, H. Breitschop, and H. Lassmann, “Accelerated myelinogenesis by dietary lipids in rat brain,” Journal of Neurochemistry, vol. 67, no. 4, pp. 1744–1750, 1996.
51. P. A. Grimaldi, “The roles of PPARs in adipocyte differentiation,” Progress in Lipid Research, vol. 40, no. 4, pp. 269–281, 2001. View at Publisher · View at Google Scholar
52. R. L. Rosenfield, A. Kentsis, D. Deplewski, and N. Ciletti, “Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors,” Journal of Investigative Dermatology, vol. 112, no. 2, pp. 226–232, 1999. View at Publisher · View at Google Scholar · View at PubMed
53. M. Schmuth, C. M. Haqq, W. J. Cairns, et al., “Peroxisome proliferator-activated receptor (PPAR)-$\beta$/$\delta$ stimulates differentiation and lipid accumulation in keratinocytes,” Journal of Investigative Dermatology, vol. 122, no. 4, pp. 971–983, 2004. View at Publisher · View at Google Scholar · View at PubMed
54. L. Michalik and W. Wahli, “Peroxisome proliferator-activated receptors (PPARs) in skin health, repair and disease,” Biochimica et Biophysica Acta, vol. 1771, no. 8, pp. 991–998, 2007. View at Publisher · View at Google Scholar · View at PubMed
55. S. Di Loreto, B. D'Angelo, M. A. D'Amico, et al., “PPAR$\beta$ agonists trigger neuronal differentiation in the human neuroblastoma cell line SH-SY5Y,” Journal of Cellular Physiology, vol. 211, no. 3, pp. 837–847, 2007. View at Publisher · View at Google Scholar · View at PubMed
56. A. Cimini and M. P. Cerù, “Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation,” to appear in Stem Cell Reviews 2008 Jun 17 Epub ahead of print.
57. J. Zhang, M. Fu, X. Zhu, et al., “Peroxisome proliferator-activated receptor $\delta$ is up-regulated during vascular lesion formation and promotes post-confluent cell proliferation in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 277, no. 13, pp. 11505–11512, 2002. View at Publisher · View at Google Scholar · View at PubMed
58. J. B. Hansen, H. Zhang, T. H. Rasmussen, R. K. Petersen, E. N. Flindt, and K. Kristiansen, “Peroxisome proliferator-activated receptor $\delta$ (PPAR$\delta$)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling,” The Journal of Biological Chemistry, vol. 276, no. 5, pp. 3175–3182, 2001. View at Publisher · View at Google Scholar · View at PubMed
59. C. Jehl-Pietri, C. Bastie, I. Gillot, S. Luquet, and P. A. Grimaldi, “Peroxisome-proliferator-activated receptor $\delta$ mediates the effects of long-chain fatty acids on post-confluent cell proliferation,” Biochemical Journal, vol. 350, no. 1, pp. 93–98, 2000. View at Publisher · View at Google Scholar
60. N. Di-Poï, L. Michalik, N. S. Tan, B. Desvergne, and W. Wahli, “The anti-apoptotic role of PPAR$\beta$ contributes to efficient skin wound healing,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 85, no. 2–5, pp. 257–265, 2003. View at Publisher · View at Google Scholar
61. D. Arsenijevic, F. de Bilbao, J. Plamondon, et al., “Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor $\beta$-deficient mice,” Journal of Cerebral Blood Flow & Metabolism, vol. 26, no. 3, pp. 433–445, 2006. View at Publisher · View at Google Scholar · View at PubMed
62. J.-B. Pialat, T.-H. Cho, O. Beuf, et al., “MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice,” NMR in Biomedicine, vol. 20, no. 3, pp. 335–342, 2007. View at Publisher · View at Google Scholar · View at PubMed
63. A. Iwashita, Y. Muramatsu, T. Yamazaki, et al., “Neuroprotective efficacy of the peroxisome proliferator-activated receptor $\delta$-selective agonists in vitro and in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 320, no. 3, pp. 1087–1096, 2007. View at Publisher · View at Google Scholar · View at PubMed
64. N. Di-Poï, N. S. Tan, L. Michalik, W. Wahli, and B. Desvergne, “Antiapoptotic role of PPAR$\beta$ in keratinocytes via transcriptional control of the Akt1 signaling pathway,” Molecular Cell, vol. 10, no. 4, pp. 721–733, 2002. View at Publisher · View at Google Scholar
65. C.-M. Hao, R. Redha, J. Morrow, and M. D. Breyer, “Peroxisome proliferator-activated receptor $\delta$ activation promotes cell survival following hypertonic stress,” The Journal of Biological Chemistry, vol. 277, no. 24, pp. 21341–21345, 2002. View at Publisher · View at Google Scholar · View at PubMed
66. E. Letavernier, J. Perez, E. Joye, et al., “Peroxisome proliferator-activated receptor $\beta$/$\delta$ exerts a strong protection from ischemic acute renal failure,” Journal of the American Society of Nephrology, vol. 16, no. 8, pp. 2395–2402, 2005. View at Publisher · View at Google Scholar · View at PubMed
67. S. A. Smith, G. R. Monteith, J. A. Robinson, N. G. Venkata, F. J. May, and S. J. Roberts-Thomson, “Effect of the peroxisome proliferator-activated receptor $\beta$ activator GW0742 in rat cultured cerebellar granule neurons,” Journal of Neuroscience Research, vol. 77, no. 2, pp. 240–249, 2004. View at Publisher · View at Google Scholar · View at PubMed
68. H. E. Hollingshead, M. G. Borland, A. N. Billin, T. M. Willson, F. J. Gonzalez, and J. M. Peters, “Ligand activation of peroxisome proliferator-activated receptor-$\beta$/$\delta$ (PPAR$\beta$/$\delta$) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms,” Carcinogenesis, vol. 29, no. 1, pp. 169–176, 2008. View at Publisher · View at Google Scholar · View at PubMed
69. L. Minghetti, “Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases,” Journal of Neuropathology and Experimental Neurology, vol. 63, no. 9, pp. 901–910, 2004.
70. P. E. Polak, S. Kalinin, C. Dello Russo, et al., “Protective effects of a peroxisome proliferator-activated receptor-$\beta$/$\delta$ agonist in experimental autoimmune encephalomyelitis,” Journal of Neuroimmunology, vol. 168, no. 1-2, pp. 65–75, 2005. View at Publisher · View at Google Scholar · View at PubMed
71. C.-H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W. A. Boisvert, and R. M. Evans, “Transcriptional repression of atherogenic inflammation: modulation by PPAR$\delta$,” Science, vol. 302, no. 5644, pp. 453–457, 2003. View at Publisher · View at Google Scholar · View at PubMed
72. S. Müller-Brüsselbach, M. Kömhoff, M. Rieck, et al., “Deregulation of tumor angiogenesis and blockade of tumor growth in PPAR$\beta$-deficient mice,” The EMBO Journal, vol. 26, no. 15, pp. 3686–3698, 2007. View at Publisher · View at Google Scholar · View at PubMed
73. Y. Fan and G.-Y. Yang, “Therapeutic angiogenesis for brain ischemia: a brief review,” Journal of Neuroimmune Pharmacology, vol. 2, no. 3, pp. 284–289, 2007. View at Publisher · View at Google Scholar · View at PubMed
74. G. J. del Zoppo, R. Milner, T. Mabuchi, S. Hung, X. Wang, and J. A. Koziol, “Vascular matrix adhesion and the blood-brain barrier,” Biochemical Society Transactions, vol. 34, no. 6, pp. 1261–1266, 2006. View at Publisher · View at Google Scholar · View at PubMed
75. G. J. del Zoppo and R. Milner, “Integrin-matrix interactions in the cerebral microvasculature,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 1966–1975, 2006. View at Publisher · View at Google Scholar · View at PubMed
76. A. Lampen, P. A. Grimaldi, and H. Nau, “Modulation of peroxisome proliferator-activated receptor $\delta$ activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation,” Molecular Pharmacology, vol. 68, no. 1, pp. 193–203, 2005. View at Publisher · View at Google Scholar · View at PubMed
77. Y. Fan, Y. Wang, Z. Tang, et al., “Suppression of pro-inflammatory adhesion molecules by PPAR-$\delta$ in human vascular endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 2, pp. 315–321, 2008. View at Publisher · View at Google Scholar · View at PubMed
78. D. Chaturvedi, S. Ray, A. K. Srivastava, and R. Chander, “$\omega$-(2-Naphthyloxy) amino alkanes as a novel class of anti-hyperglycemic and lipid lowering agents,” Bioorganic & Medicinal Chemistry, vol. 16, no. 5, pp. 2489–2498, 2008. View at Publisher · View at Google Scholar · View at PubMed
79. M. K. Storch, A. Stefferl, U. Brehm, et al., “Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology,” Brain Pathology, vol. 8, no. 4, pp. 681–694, 1998.
80. T. G. Johns, N. Kerlero de Rosbo, K. K. Menon, S. Abo, M. F. Gonzales, and C. C. Bernard, “Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis,” The Journal of Immunology, vol. 154, no. 10, pp. 5536–5541, 1995.
81. S. Schmidt, E. Moric, M. Schmidt, M. Sastre, D. L. Feinstein, and M. T. Heneka, “Anti-inflammatory and antiproliferative actions of PPAR-$\gamma$ agonists on T lymphocytes derived from MS patients,” Journal of Leukocyte Biology, vol. 75, no. 3, pp. 478–485, 2004. View at Publisher · View at Google Scholar · View at PubMed
82. H. Rampler, I. Weinhofer, A. Netik, et al., “Evaluation of the therapeutic potential of PPAR$\alpha$ agonists for X-linked adrenoleukodystrophy,” Molecular Genetics and Metabolism, vol. 80, no. 4, pp. 398–407, 2003. View at Publisher · View at Google Scholar
83. E. Galea, M. T. Heneka, C. Dello Russo, and D. L. Feinstein, “Intrinsic regulation of brain inflammatory responses,” Cellular and Molecular Neurobiology, vol. 23, no. 4-5, pp. 625–635, 2003. View at Publisher · View at Google Scholar
84. M. Seimandi, G. Lemaire, A. Pillon, et al., “Differential responses of PPAR$\alpha$, PPAR$\delta$, and PPAR$\gamma$ reporter cell lines to selective PPAR synthetic ligands,” Analytical Biochemistry, vol. 344, no. 1, pp. 8–15, 2005. View at Publisher · View at Google Scholar · View at PubMed
85. J. L. M. Madrigal, S. Kalinin, J. C. Richardson, and D. L. Feinstein, “Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta,” Journal of Neurochemistry, vol. 103, no. 5, pp. 2092–2101, 2007. View at Publisher · View at Google Scholar · View at PubMed